4//SEC Filing
HALE DAVID F 4
Accession 0001209191-24-004016
CIK 0001260990other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:03 PM ET
Size
7.8 KB
Accession
0001209191-24-004016
Insider Transaction Report
Form 4
HALE DAVID F
Director
Transactions
- Purchase
Common Stock
2024-02-23$9.04/sh+266$2,405→ 29,673 total(indirect: By LLC) - Purchase
Common Stock
2024-02-23$9.04/sh+714$6,455→ 714 total
Holdings
- 917(indirect: By Hale Trading Company)
Common Stock
Footnotes (1)
- [F1]The shares of common stock were acquired directly from another director of the Issuer, Robert James Wills, in a private sale. The price per share was based on the closing price of the Issuer's common stock on February 23, 2024.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001024004
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:03 PM ET
- Size
- 7.8 KB